These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 25870973
1. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS. Nirwane A, Pawar V, Majumdar A. J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973 [Abstract] [Full Text] [Related]
2. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction. Kaur T, Goel RK, Balakumar P. Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371 [Abstract] [Full Text] [Related]
3. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction. Verma S, Reddy K, Balakumar P. Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121 [Abstract] [Full Text] [Related]
4. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats. Jindal S, Singh M, Balakumar P. Int J Cardiol; 2008 Aug 29; 128(3):383-91. PubMed ID: 17658639 [Abstract] [Full Text] [Related]
5. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction. Jyoti U, Kansal SK, Kumar P, Goyal S. Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb 29; 389(2):167-75. PubMed ID: 26497187 [Abstract] [Full Text] [Related]
6. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat. Kaur J, Reddy K, Balakumar P. Cardiovasc Toxicol; 2010 Sep 29; 10(3):227-38. PubMed ID: 20694523 [Abstract] [Full Text] [Related]
7. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat. Chakkarwar VA. Vascul Pharmacol; 2011 Sep 29; 55(5-6):163-8. PubMed ID: 21864717 [Abstract] [Full Text] [Related]
8. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Knorr M, Hausding M, Kröller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Münzel T. Arterioscler Thromb Vasc Biol; 2011 Oct 29; 31(10):2223-31. PubMed ID: 21757654 [Abstract] [Full Text] [Related]
9. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction. Shah DI, Singh M. Vascul Pharmacol; 2006 Mar 29; 44(3):177-82. PubMed ID: 16442349 [Abstract] [Full Text] [Related]
10. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Balakumar P, Sharma R, Singh M. Pharmacol Res; 2008 Mar 29; 58(5-6):356-63. PubMed ID: 18951979 [Abstract] [Full Text] [Related]
11. Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals. Taneja G, Mahadevan N, Balakumar P. Cardiovasc Toxicol; 2013 Jun 29; 13(2):110-22. PubMed ID: 23208382 [Abstract] [Full Text] [Related]
12. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome. Kagota S, Tada Y, Nejime N, Nakamura K, Kunitomo M, Shinozuka K. Can J Physiol Pharmacol; 2011 May 29; 89(5):355-64. PubMed ID: 21619437 [Abstract] [Full Text] [Related]
13. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. White R, Hiley CR. Br J Pharmacol; 1997 Dec 29; 122(8):1573-84. PubMed ID: 9422801 [Abstract] [Full Text] [Related]
14. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities. Kathuria S, Mahadevan N, Balakumar P. Mol Cell Biochem; 2013 Feb 29; 374(1-2):61-72. PubMed ID: 23149826 [Abstract] [Full Text] [Related]
15. Treatment with n-3 polyunsaturated fatty acids reverses endothelial dysfunction and oxidative stress in experimental menopause. Gortan Cappellari G, Losurdo P, Mazzucco S, Panizon E, Jevnicar M, Macaluso L, Fabris B, Barazzoni R, Biolo G, Carretta R, Zanetti M. J Nutr Biochem; 2013 Jan 29; 24(1):371-9. PubMed ID: 23159066 [Abstract] [Full Text] [Related]
16. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism. Dhar I, Dhar A, Wu L, Desai K. J Pharmacol Exp Ther; 2012 Jul 29; 342(1):196-204. PubMed ID: 22518022 [Abstract] [Full Text] [Related]
17. Activation of protein kinase A improves vascular endothelial dysfunction. Shah DI, Singh M. Endothelium; 2006 Jul 29; 13(4):267-77. PubMed ID: 16990183 [Abstract] [Full Text] [Related]
18. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779 [Abstract] [Full Text] [Related]
19. Persistence of EDHF pathway and impairment of the nitric oxide pathway after chronic mercury chloride exposure in rats: mechanisms of endothelial dysfunction. Omanwar S, Ravi K, Fahim M. Hum Exp Toxicol; 2011 Nov 21; 30(11):1777-84. PubMed ID: 21148200 [Abstract] [Full Text] [Related]
20. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus. Schäfer A, Flierl U, Vogt C, Menninger S, Tas P, Ertl G, Bauersachs J. Pharmacol Res; 2007 Sep 21; 56(3):217-23. PubMed ID: 17669665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]